DOJ Intervenes, Settles Whistleblower Case Involving Off-Label Marketing to Military Physicians
Novo Nordisk to Repay $25 Million in False Claims
BALTIMORE — A false claims case against global pharmaceutical firm Novo Nordisk came to a close today with the announcement of a $25 million settlement. According to the complaint, filed under seal by the law firm of Wates & Kraus, LLP and co-counsel, Hargrove & Rea, in October 2008, the company’s methodical and aggressive promotion of an expensive hemophilia drug for unapproved uses not only subjected soldiers and civilians to potentially deadly side effects, but it also cost the government millions in false reimbursement claims. Read more…
